Contribute Try STAT+ Today

A former study coordinator at a company hired to run a clinical trial of a GlaxoSmithKline (GSK) asthma medication has been indicted for falsifying data, the fourth individual to run afoul of authorities in connection with the research.

The employee, Jessica Palacio, 34, worked at Unlimited Medical Research, which is based in Miami and was one of several companies tapped to help with a study designed to assess the safety and effectiveness of Advair Diskus for children between 4 and 11 years old, according to court documents. Glaxo had hired Parexel, a clinical research organization, to coordinate the trial.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.